{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:29:37Z","timestamp":1791358177221,"version":"4.3.1"},"reference-count":50,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Merck, Sharpe and Dohme Corporation\/University of Montreal"},{"DOI":"10.13039\/501100000193","name":"International Development Research Centre","doi-asserted-by":"publisher","award":["108591-001"],"award-info":[{"award-number":["108591-001"]}],"id":[{"id":"10.13039\/501100000193","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fonds de recherche du Qu\u00e9bec Sant\u00e9"},{"name":"IUCPQ Foundation and Research Center"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Many people living with diabetes also have nonalcoholic fatty liver disease (NAFLD). Interleukin-6 (IL-6) is involved in both diseases, interacting with both membrane-bound (classical) and circulating (trans-signaling) soluble receptors. We investigated whether secretion of IL-6 trans-signaling coreceptors are altered in NAFLD by diabetes and whether this might associate with the severity of fatty liver disease. Secretion patterns were investigated with use of human hepatocyte, stellate, and monocyte cell lines. Associations with liver pathology were investigated in two patient cohorts: 1) biopsy-confirmed steatohepatitis and 2) class 3 obesity. We found that exposure of stellate cells to high glucose and palmitate increased IL-6 and soluble gp130 (sgp130) secretion. In line with this, plasma sgp130 in both patient cohorts positively correlated with HbA1c, and subjects with diabetes had higher circulating levels of IL-6 and trans-signaling coreceptors. Plasma sgp130 strongly correlated with liver stiffness and was significantly increased in subjects with F4 fibrosis stage. Monocyte activation was associated with reduced sIL-6R secretion. These data suggest that hyperglycemia and hyperlipidemia can directly impact IL-6 trans-signaling and that this may be linked to enhanced severity of NAFLD in patients with concomitant diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>IL-6 and its circulating coreceptor sgp130 are increased in people with fatty liver disease and steatohepatitis. High glucose and lipids stimulated IL-6 and sgp130 secretion from hepatic stellate cells. sgp130 levels correlated with HbA1c, and diabetes concurrent with steatohepatitis further increased circulating levels of all IL-6 trans-signaling mediators. Circulating sgp130 positively correlated with liver stiffness and hepatic fibrosis. Metabolic stress to liver associated with fatty liver disease might shift the balance of IL-6 classical versus trans-signaling, promoting liver fibrosis that is accelerated by diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db23-0171","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T18:10:50Z","timestamp":1695838250000},"page":"1820-1834","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":39,"title":["IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease"],"prefix":"10.2337","volume":"72","author":[{"given":"Aysim","family":"Gunes","sequence":"first","affiliation":[{"name":"1Institut de recherches cliniques de Montr\u00e9al (IRCM), Montreal, Quebec, Canada"},{"name":"2Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"3Montreal Diabetes Research Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Schmitt","sequence":"additional","affiliation":[{"name":"1Institut de recherches cliniques de Montr\u00e9al (IRCM), Montreal, Quebec, Canada"},{"name":"4Programmes de biologie mol\u00e9culaire, Facult\u00e9 de m\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bilodeau","sequence":"additional","affiliation":[{"name":"5D\u00e9partement de radiologie, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Huet","sequence":"additional","affiliation":[{"name":"5D\u00e9partement de radiologie, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Belblidia","sequence":"additional","affiliation":[{"name":"5D\u00e9partement de radiologie, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Baldwin","sequence":"additional","affiliation":[{"name":"1Institut de recherches cliniques de Montr\u00e9al (IRCM), Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne-Marie","family":"Giard","sequence":"additional","affiliation":[{"name":"6Liver Unit, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), D\u00e9partement de m\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Biertho","sequence":"additional","affiliation":[{"name":"7Centre de recherche de l\u2019Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, Universit\u00e9 Laval, Quebec City, Quebec, Canada"},{"name":"8D\u00e9partement de chirurgie, Facult\u00e9 de m\u00e9decine, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Lafortune","sequence":"additional","affiliation":[{"name":"7Centre de recherche de l\u2019Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, Universit\u00e9 Laval, Quebec City, Quebec, Canada"},{"name":"8D\u00e9partement de chirurgie, Facult\u00e9 de m\u00e9decine, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Yves","family":"Couture","sequence":"additional","affiliation":[{"name":"7Centre de recherche de l\u2019Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, Universit\u00e9 Laval, Quebec City, Quebec, Canada"},{"name":"9D\u00e9partement de biologie mol\u00e9culaire, biochimie m\u00e9dicale et pathologie, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Cheung","sequence":"additional","affiliation":[{"name":"10Gastroenterology and Hepatology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bich N.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"11D\u00e9partement de pathologie et biologie cellulaire, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithan","family":"Galun","sequence":"additional","affiliation":[{"name":"12Goldyne Savad Institute of Gene Therapy, Hadassah Hebrew University Hospital, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"B\u00e9meur","sequence":"additional","affiliation":[{"name":"13D\u00e9partement de nutrition, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"},{"name":"14Labo H\u00e9patoNeuro, Centre de recherche du CHUM, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bilodeau","sequence":"additional","affiliation":[{"name":"6Liver Unit, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), D\u00e9partement de m\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Laplante","sequence":"additional","affiliation":[{"name":"3Montreal Diabetes Research Centre, Montreal, Quebec, Canada"},{"name":"7Centre de recherche de l\u2019Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, Universit\u00e9 Laval, Quebec City, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Tang","sequence":"additional","affiliation":[{"name":"5D\u00e9partement de radiologie, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Faraj","sequence":"additional","affiliation":[{"name":"1Institut de recherches cliniques de Montr\u00e9al (IRCM), Montreal, Quebec, Canada"},{"name":"2Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"3Montreal Diabetes Research Centre, Montreal, Quebec, Canada"},{"name":"13D\u00e9partement de nutrition, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-1440","authenticated-orcid":false,"given":"Jennifer L.","family":"Estall","sequence":"additional","affiliation":[{"name":"1Institut de recherches cliniques de Montr\u00e9al (IRCM), Montreal, Quebec, Canada"},{"name":"2Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"3Montreal Diabetes Research Centre, Montreal, Quebec, Canada"},{"name":"4Programmes de biologie mol\u00e9culaire, Facult\u00e9 de m\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"2023112019543108200_B1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"2023112019543108200_B2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2023112019543108200_B3","article-title":"group. A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","journal-title":"Hepatology"},{"key":"2023112019543108200_B4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1080\/07853890.2021.1956685","article-title":"Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)","volume":"53","author":"Cuthbertson","year":"2021","journal-title":"Ann Med"},{"key":"2023112019543108200_B5","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2337\/dc06-2289","article-title":"Interleukin-6 in obese children and adolescents with and without glucose intolerance","volume":"30","author":"Yeste","year":"2007","journal-title":"Diabetes Care"},{"key":"2023112019543108200_B6","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1210\/jc.2011-1497","article-title":"The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans","volume":"96","author":"Charles","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2023112019543108200_B7","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2023112019543108200_B8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41575-021-00473-x","article-title":"New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology","volume":"18","author":"Giraldez","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2023112019543108200_B9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J Hepatol"},{"key":"2023112019543108200_B10","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"2023112019543108200_B11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2249.2009.03916.x","article-title":"An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease","volume":"156","author":"Lemmers","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2023112019543108200_B12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.metabol.2013.01.019","article-title":"Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness","volume":"62","author":"Weiss","year":"2013","journal-title":"Metabolism"},{"key":"2023112019543108200_B13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/db09-1316","article-title":"Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome","volume":"59","author":"Nikolajuk","year":"2010","journal-title":"Diabetes"},{"key":"2023112019543108200_B14","first-page":"1005","article-title":"Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy","volume":"22","author":"Chen","year":"2016","journal-title":"Mol Vis"},{"key":"2023112019543108200_B15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jmri.23731","article-title":"Magnetic resonance elastography of liver: technique, analysis, and clinical applications","volume":"37","author":"Venkatesh","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"2023112019543108200_B16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jmri.22066","article-title":"Repeatability of magnetic resonance elastography for quantification of hepatic stiffness","volume":"31","author":"Hines","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"2023112019543108200_B17","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1007\/s00330-021-08381-z","article-title":"MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T","volume":"32","author":"Tang","year":"2022","journal-title":"Eur Radiol"},{"key":"2023112019543108200_B18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"2023112019543108200_B19","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2023112019543108200_B20","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"2023112019543108200_B21","doi-asserted-by":"crossref","first-page":"18045","DOI":"10.1038\/s41598-021-96966-5","article-title":"Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD","volume":"11","author":"Pantano","year":"2021","journal-title":"Sci Rep"},{"key":"2023112019543108200_B22","doi-asserted-by":"crossref","first-page":"16186","DOI":"10.1074\/jbc.M116.718551","article-title":"Different soluble forms of the interleukin-6 family signal transducer gp130 fine-tune the blockade of interleukin-6 trans-signaling","volume":"291","author":"Wolf","year":"2016","journal-title":"J Biol Chem"},{"key":"2023112019543108200_B23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"2023112019543108200_B24","unstructured":"Reference Values for Biochemical Tests - Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al. Accessed 29 October 2019. Available from https:\/\/www.chumontreal.qc.ca\/sites\/default\/files\/2022-10\/Valeurs%20r\u00e9f\u00e9rences%20-%20Biochimie-%202022-10-11%20%281%29.pdf"},{"key":"2023112019543108200_B25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00384-018-3069-8","article-title":"Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases","volume":"33","author":"Nikolaus","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"2023112019543108200_B26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0165-5728(99)00120-4","article-title":"CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis","volume":"99","author":"Padberg","year":"1999","journal-title":"J Neuroimmunol"},{"key":"2023112019543108200_B27","doi-asserted-by":"crossref","first-page":"e0133494","DOI":"10.1371\/journal.pone.0133494","article-title":"Obesity is a positive modulator of IL-6R and IL-6 expression in the subcutaneous adipose tissue: significance for metabolic inflammation","volume":"10","author":"Sindhu","year":"2015","journal-title":"PLoS One"},{"key":"2023112019543108200_B28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/met.2016.0135","article-title":"Circulating soluble IL-6 receptor concentration and visceral adipocyte size are related to insulin resistance in Taiwanese adults with morbid obesity","volume":"15","author":"Kuo","year":"2017","journal-title":"Metab Syndr Relat Disord"},{"key":"2023112019543108200_B29","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/hep4.1603","article-title":"Elevated glycated hemoglobin is associated with liver fibrosis, as assessed by elastography, in a population-based study of Mexican Americans","volume":"4","author":"Watt","year":"2020","journal-title":"Hepatol Commun"},{"key":"2023112019543108200_B30","doi-asserted-by":"crossref","first-page":"C873","DOI":"10.1152\/ajpcell.00604.2020","article-title":"The intersection of metformin and inflammation","volume":"320","author":"Bharath","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"2023112019543108200_B31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2214\/AJR.15.14552","article-title":"Ultrasound elastography and MR elastography for assessing liver fibrosis: part 1, principles and techniques","volume":"205","author":"Tang","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"2023112019543108200_B32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejrad.2017.11.003","article-title":"MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease","volume":"98","author":"Costa-Silva","year":"2018","journal-title":"Eur J Radiol"},{"key":"2023112019543108200_B33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1148\/radiol.2016160685","article-title":"Diagnostic performance of MR elastography and vibration-controlled transient elastography in the detection of hepatic fibrosis in patients with severe to morbid obesity","volume":"283","author":"Chen","year":"2017","journal-title":"Radiology"},{"key":"2023112019543108200_B34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"2023112019543108200_B35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2023112019543108200_B36","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1007\/s00330-019-06331-4","article-title":"Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis","volume":"29","author":"Lefebvre","year":"2019","journal-title":"Eur Radiol"},{"key":"2023112019543108200_B37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.atherosclerosis.2010.08.074","article-title":"Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance","volume":"213","author":"Zuliani","year":"2010","journal-title":"Atherosclerosis"},{"key":"2023112019543108200_B38","doi-asserted-by":"crossref","first-page":"103062","DOI":"10.1016\/j.ebiom.2020.103062","article-title":"Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes","volume":"61","author":"Bowker","year":"2020","journal-title":"EBioMedicine"},{"key":"2023112019543108200_B39","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3390\/ijms22041774","article-title":"IL-6 reduces mitochondrial replication, and IL-6 receptors reduce chronic inflammation in NAFLD and type 2 diabetes","volume":"22","author":"Skuratovskaia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023112019543108200_B40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.31658","article-title":"Myeloid-cell-specific IL-6 signaling promotes microRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis","volume":"74","author":"Hou","year":"2021","journal-title":"Hepatology"},{"key":"2023112019543108200_B41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2023112019543108200_B42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12964-019-0356-0","article-title":"Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor \u03b1 to gp130 expression: fusing experimental insights and dynamic modelling","volume":"17","author":"Reeh","year":"2019","journal-title":"Cell Commun Signal"},{"key":"2023112019543108200_B43","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/hep.30774","article-title":"IL-6 trans-signaling controls liver regeneration after partial hepatectomy","volume":"70","author":"Fazel Modares","year":"2019","journal-title":"Hepatology"},{"key":"2023112019543108200_B44","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1096\/fj.99-0913com","article-title":"Liver regeneration induced by a designer human IL-6\/sIL-6R fusion protein reverses severe hepatocellular injury","volume":"14","author":"Galun","year":"2000","journal-title":"FASEB J"},{"key":"2023112019543108200_B45","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/gast.2000.20236","article-title":"Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration","volume":"119","author":"Peters","year":"2000","journal-title":"Gastroenterology"},{"key":"2023112019543108200_B46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.28874","article-title":"IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice","volume":"65","author":"Bergmann","year":"2017","journal-title":"Hepatology"},{"key":"2023112019543108200_B47","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jhep.2022.07.029","article-title":"Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling","volume":"77","author":"Rosenberg","year":"2022","journal-title":"J Hepatol"},{"key":"2023112019543108200_B48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2015.02.006","article-title":"Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance","volume":"21","author":"Kraakman","year":"2015","journal-title":"Cell Metab"},{"key":"2023112019543108200_B49","doi-asserted-by":"crossref","first-page":"e0179099","DOI":"10.1371\/journal.pone.0179099","article-title":"Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice","volume":"12","author":"Kammoun","year":"2017","journal-title":"PLoS One"},{"key":"2023112019543108200_B50","doi-asserted-by":"crossref","article-title":"Peripheral sgp130-mediated trans-signaling blockade induces obesity and insulin resistance in mice via PPAR\u03b1 suppression","author":"Lanton","DOI":"10.1101\/2020.09.24.309716"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/72\/12\/1820\/738536\/db230171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/72\/12\/1820\/738536\/db230171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:57:32Z","timestamp":1700492252000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/72\/12\/1820\/153602\/IL-6-Trans-Signaling-Is-Increased-in-Diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,9,27]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db23-0171","relation":{},"ISSN":["0012-1797"],"issn-type":[{"value":"0012-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,27]]}}}